Austar Lifesciences Limited (HKG:6118)

Hong Kong · Delayed Price · Currency is HKD

0.7350

+0.0350 (5.00%)

Aug 20, 2026, 4:09 PM HKT

-45.96% (1Y)

Market Cap	379.31M -45.6%
Revenue (ttm)	1.70B +2.0%
Net Income	37.62M +110.2%
EPS	0.07 +110.2%
Shares Out	512.58M
PE Ratio	10.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	307,000
Open	0.7200
Previous Close	0.7000
Day's Range	0.7150 - 0.7700
52-Week Range	0.6500 - 1.6000
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems; clean room, automation control, ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1991

Employees 1,468

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6118

Full Company Profile

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY Financial Statements